Prostate cancer drug that can halve death risk to be offered to thousands in England
At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects Thousands of men with advanced prostate cancer in England are to be offered a drug that can halve the risk of death. In guidance published on Friday, the National (…)
Site référencé:
The Guardian (South&CentralAsia)
3333.jpg?width=140&quality=85&auto=format&fit=max&s=4ef98f38f4c778416f19eff8a360aecc, 3333.jpg?width=460&quality=85&auto=format&fit=max&s=1150db78d91fedf560db661d7de6d353, 3333.jpg?width=700&quality=85&auto=format&fit=max&s=b88b50e1202d2797417341d7e43a97ab
The Guardian (South&CentralAsia)
‘What does it mean ? No one knows’ : six-seven meme invades UK classrooms
23/10/2025
Ministers confirm plans to reduce London’s affordable housing quotas
23/10/2025
Fatty steaks and coffee with maple syrup : Erling Haaland lets us in on life at home
23/10/2025
Herbal supplements were supposed to make them healthier. Instead, they got sick
23/10/2025
Stellan Skarsgård says he is living ‘on overtime’ since having a stroke three years ago
23/10/2025
Women’s marathon world record-holder Chepngetich handed three-year doping ban
23/10/2025